NLM Logo

Brimonidine Tartrate, Timolol Maleate Drug Combination MeSH Descriptor Data 2022


MeSH Heading
Brimonidine Tartrate, Timolol Maleate Drug Combination
Tree Number(s)
D02.033.100.624.915.500
D02.033.755.624.915.500
D02.092.063.624.915.500
D02.886.675.867.768.500
D03.383.129.708.867.768.500
D03.633.100.857.070.500
D26.310.312
Unique ID
D000068599
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068599
Scope Note
A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.
Entry Term(s)
Brimonidine Tartrate-Timolol Maleate
Brimonidine Tartrate-Timolol Maleate Drug Combination
Combigan
Pharm Action
Adrenergic beta-Antagonists
Adrenergic alpha-2 Receptor Agonists
Registry Number
0
Public MeSH Note
2016; BRIMONIDINE TARTRATE-TIMOLOL MALEATE DRUG COMBINATION was indexed under QUINOXALINES 2011-2015, under TIMOLOL 2011-2015, and under DRUG COMBINATIONS 2011-2015
History Note
2016 (2011)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2016/05/27
Brimonidine Tartrate, Timolol Maleate Drug Combination Preferred
Combigan Narrower
page delivered in 0.175s